CAMBRIDGE, England, March 17, 2026 /PRNewswire/ -- Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, ...

When clinicians contemplate the use of a new predictive technology in their practice, such as a nomogram, there is always a question of whether the new test is beneficial to their own clinical ...

Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...

CAMBRIDGE, England, March 17, 2026 /PRNewswire/ -- Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, ...